Infections We Could Treat But Now Fail To Control
Antimicrobial resistance (AMR) is one of the greatest challenges of modern healthcare. Once-treatable infections are now becoming untreatable, leading to prolonged illness, higher mortality rates, and spiraling healthcare costs. Resistance is not only a medical problem but also a societal one, as the spread of resistant infections disrupts hospitals, clinics, and even workplaces.
This article explores the causes of serious infections that were once easily managed but are now increasingly resistant to treatment. We will also highlight the most common antimicrobial-resistant infections spreading globally, particularly in healthcare environments.
Causes of Serious Infections That Were Once Treatable
Several serious infections, which could once be managed with standard antibiotics, are now showing resistance due to various factors:
Overuse and Misuse of Antibiotics
- Inappropriate prescribing of antibiotics for viral infections (e.g., colds, flu) has led to resistance.
- Overuse in agriculture and animal husbandry exacerbates the problem by exposing bacteria to antibiotics on a massive scale.
Incomplete Treatment Courses
- Patients stopping antibiotics early when they feel better allows bacteria to survive and mutate, developing resistance.
- This is debatable because there is no study or data that prove antibiotics must be given for 5, 7, 10 or 14 days. According to phrocokinetics when adequate peak occurs (after 3 doses) bacteria are dead, and the patient starts showing sings of getting better, temperature drops to normal, and pains and rash subside. This I have used to differentiate bacterial infection from viral and antimicrobia resistant bacterial infections. In my book Maya Bring Tears of happiness I explaind this but WHO continue to promote this even though I said the antibiotics are excreted in urine, and feaces that pollutes soil and water making more ARM in the environment.
Healthcare-Associated Infections
- Hospitals and clinics, despite efforts to maintain sterility, are hotspots for resistant bacteria due to the high usage of antimicrobials and close patient contact.
Global Travel
- Increased global travel spreads resistant pathogens across borders, making AMR a worldwide issue.
Lack of New Antibiotics
- Few new antibiotics are being developed, leaving healthcare systems reliant on aging drugs that are becoming ineffective.
Common Antimicrobial-Resistant Infections Spreading Worldwide
Here is a list of the most concerning AMR infections, their causes, and their impacts:
InfectionCausative AgentResistance ConcernPrimary Settings of Spread
Methicillin-Resistant Staphylococcus aureus (MRSA) | Staphylococcus aureus | Resistant to methicillin and related drugs | Hospitals, clinics, and nursing homes |
Multidrug-Resistant Tuberculosis (MDR-TB) | Mycobacterium tuberculosis | Resistant to isoniazid and rifampin | Developing countries and high-density areas |
Vancomycin-Resistant Enterococci (VRE) | Enterococcus species | Resistant to vancomycin | ICU units, surgical wards |
Carbapenem-Resistant Enterobacteriaceae (CRE) | Klebsiella pneumoniae, E. coli | Resistant to carbapenems, last-resort antibiotics | Hospitals and long-term care facilities |
Drug-Resistant Gonorrhea | Neisseria gonorrhoeae | Resistant to ceftriaxone and azithromycin | Clinics, sexually transmitted infection clinics |
Clostridioides difficile (C. diff) | Clostridioides difficile | Resistance to multiple antibiotics | Hospitals, outpatient settings |
Multidrug-Resistant Acinetobacter | Acinetobacter baumannii | Resistant to carbapenems and other classes | ICU units, ventilated patients |
Candida auris | Candida auris (fungus) | Resistant to antifungal drugs | Hospitals, particularly ICU and surgical units |
ESBL-Producing Bacteria | Extended-spectrum beta-lactamase producers (E. coli, Klebsiella) | Resistant to third-generation cephalosporins | Community and healthcare settings |
Why These Infections Are Spreading So Rapidly
Colonization in Healthcare Settings
- Hospitals and clinics act as reservoirs for resistant bacteria and fungi, where infections often spread through contaminated surfaces, devices, or unwashed hands.
- Antibiotic use in these settings further promotes resistance.
High Patient Turnover
- Overcrowded facilities and insufficient infection control measures accelerate the spread of resistant pathogens.
Lack of Awareness
- Many people remain unaware of the risks of AMR, contributing to poor hygiene practices and self-medication.
Global Connectivity
- Resistant strains are carried across borders by travelers, creating global challenges.
Environmental Factors
- Resistant bacteria are increasingly found in water, soil, and food supplies, which can lead to community-acquired infections.
Key Actions to Combat the Spread
Strengthening Infection Control
- Enforce strict hygiene and sterilization protocols in hospitals and clinics.
- Use antimicrobial stewardship programs to guide appropriate prescribing.
Promoting Public Awareness
- Educate communities about the dangers of AMR and encourage proper antibiotic use.
Enhancing Surveillance
- Monitor the spread of resistant infections and share data across regions to implement timely interventions.
Developing Alternatives
- Invest in research for new antibiotics, vaccines, and alternative treatments, such as bacteriophages and probiotics.
Policy and Legislation
- Implement laws to reduce antibiotic use in agriculture and encourage the development of new drugs.
Conclusion
The spread of antimicrobial-resistant infections is a critical global health issue, with significant implications for patients, healthcare systems, and economies. Infections like MRSA, MDR-TB, CRE, and Candida auris are colonizing hospitals, clinics, and public spaces, making them difficult to treat and control.
It is imperative for governments, healthcare providers, and individuals to take collective action to prevent further resistance and protect future generations. Early identification and management of infections, responsible antibiotic use, and investment in innovative solutions are essential to combat this growing threat. Together, we can slow the spread of AMR and safeguard the efficacy of lifesaving treatments.